Capricor Therapeutics Newsroom

JonesTrading Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsDec 5 16:31 ET

Oppenheimer Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $43

Moomoo NewsDec 5 12:35 ET

Piper Sandler Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsDec 2 07:32 ET

Oppenheimer Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $43

Moomoo NewsNov 21 08:31 ET

Capricor Therapeutics Analyst Ratings

BenzingaNov 18 07:19 ET

Capricor Therapeutics Initiated With a Buy at JonesResearch

TipRanksNov 18 05:11 ET

Maxim Group Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsNov 15 15:31 ET

Cantor Fitzgerald Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Raises Target Price to $30

Moomoo NewsNov 14 08:31 ET

Oppenheimer Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $43

Moomoo NewsNov 14 08:31 ET

Piper Sandler Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsNov 14 07:34 ET

H.C. Wainwright Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $77

Moomoo NewsNov 14 06:31 ET

Capricor Therapeutics: Strategic Positioning and Financial Stability Drive Buy Rating

TipRanksNov 14 06:20 ET

Capricor Therapeutics Analyst Ratings

BenzingaOct 21 12:06 ET

Piper Sandler Initiates Capricor Therapeutics(CAPR.US) With Buy Rating, Announces Target Price $35

Moomoo NewsOct 21 05:31 ET

Capricor Therapeutics Initiated With an Overweight at Piper Sandler

TipRanksOct 21 05:30 ET

Buy Rating for Capricor Therapeutics: Promising Deramiocel Development and Strategic Partnerships

TipRanksOct 21 05:19 ET

Oppenheimer Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $43

Moomoo NewsOct 14 08:31 ET

Capricor Therapeutics (CAPR) Receives a Buy From Oppenheimer

TipRanksOct 14 07:37 ET

Capricor Therapeutics Price Target Raised to $77.00/Share From $40.00 by HC Wainwright & Co.

Dow JonesOct 11 06:36 ET

H.C. Wainwright Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Raises Target Price to $77

Moomoo NewsOct 11 06:36 ET